• Sulfo-Cy5 Carboxylic Acid for Mucosal Imaging

  2026-08-25

  Sulfo-Cy5 carboxylic acid supports aqueous fluorescence imaging of proteins, peptides, and intestinal vaccine systems. This article explains how to use its optical and chemical properties to distinguish distribution, retention, and biological targeting without overstating what fluorescence alone can prove.

• LC-MS/MS Metabolomics of Carbapenemase Resistance

  2026-08-24

  A 2025 reference study used LC-MS/MS metabolomics and supervised machine learning to distinguish carbapenemase-producing Enterobacterales from non-CPE isolates in antibiotic-free conditions. Its 21 candidate biomarkers and pathway-level findings support faster resistance detection while also revealing why external validation and targeted assay development remain necessary.

• ECL Western Blotting Substrate: Practical Guide

  2026-08-24

  ECL Western Blotting Substrate (SKU K2187) is a luminol-based horseradish peroxidase detection reagent for sensitive, nonradioactive protein detection by chemiluminescence in immunoblots. It is intended for HRP-based Western blot assays using X-ray film or CCD imaging, not for fluorescent or radioisotopic detection workflows.

• PLGA Nano-Adjuvant Enhances Mucosal Immunity in Chicks

  2026-08-23

  A 2026 Poultry Science study developed PEI-LSP-RA-PLGA, a layered PLGA nanoparticle adjuvant designed to combine sustained antigen delivery with intestinal immune targeting. In chicks receiving an inactivated H9N2 vaccine, the formulation enhanced systemic IgG, intestinal IgA, immune-cell responses, and intestinal tissue features while implicating CCR9/CCR6-associated chemokine signaling and mucosal immune pathways.

• Everolimus (RAD001) Assay Workflow Guide

  2026-08-22

  Build more informative mTOR inhibition experiments with Everolimus (RAD001), from controlled stock preparation to orthogonal measurements of growth arrest and cell death. This workflow helps distinguish cancer cell proliferation inhibition from cytotoxicity in cell-based assays and supports better interpretation of renal and ovarian cancer models.

• From Fluorescent Signal to Mucosal Insight

  2026-08-21

  How Sulfo-Cy5 carboxylic acid can help translational researchers connect nanoadjuvant biodistribution with mucosal immune function—while keeping fluorescence evidence distinct from biological causality.

• AI-10-49 in CBFβ-SMMHC Leukemia Research

  2026-08-20

  AI-10-49 enables mechanism-led acute myeloid leukemia research by disrupting the CBFβ-SMMHC–RUNX1 interaction rather than applying a nonspecific cytotoxic challenge. Pairing short exposure mechanistic assays with longer-term viability, transcriptional, and in vivo studies helps connect RUNX1 reactivation to the MYCN/eIF4G1 survival axis.

• VE-822: A Precision Assay Strategy for ATR Biology

  2026-08-20

  VE-822 is a potent ATR inhibitor for dissecting replication-stress signaling and therapeutic selectivity. This article develops a model-selection and assay-design framework inspired by personalized iPSC screening, offering a distinct route to stronger PDAC and DNA damage response studies.

• Structure-Guided SARS-CoV-2 Proteomimetics

  2026-08-19

  This study uses structure-guided alanine mutagenesis and conformational constraint to create proteomimetics that reproduce key hACE2 recognition elements at the SARS-CoV-2 Spike receptor-binding interface. The linked construct, compound 28, disrupted S-RBD/hACE2 binding, inhibited pseudovirus entry, and showed stability and permeability characteristics relevant to intranasal antiviral development.

• Hesperadin: Aurora B Kinase Inhibitor Workflows

  2026-08-19

  Hesperadin provides a practical way to connect Aurora B activity with histone H3 phosphorylation, chromosome segregation, cytokinesis, and polyploidization. This workflow-focused guide covers dose design, checkpoint-oriented assays, controls, and troubleshooting for reproducible mitosis and cancer research.

• Triptolide (PG490): Rewiring Transcription for Translation

  2026-08-18

  Triptolide, also known as PG490, is more than a potent cytotoxic compound: it is a strategic perturbation tool for testing how transcriptional dependence shapes cancer, immune, inflammatory, and developmental phenotypes. This article connects its CDK7–RNA polymerase II mechanism with evidence from Xenopus pluripotency research and provides practical guidance for translational study design.

• DAF-2 Diacetate for NO Imaging Workflows

  2026-08-18

  DAF-2 diacetate enables sensitive, retention-based nitric oxide measurements across live cells, tissue preparations, and exploratory plant assays. This guide translates its chemistry into practical workflows for NO signaling studies, including sulfur-dependent soybean nodule senescence, with controls and troubleshooting strategies for reliable interpretation.

• Obeticholic Acid: FXR Strategy for Fibrosis Research

  2026-08-17

  A translational framework for using Obeticholic Acid as an FXR-centered tool in bile acid regulation, cholestasis, portal hypertension, hepatic inflammation, and liver fibrosis research, while distinguishing established target biology from emerging combination hypotheses.

• Meropenem trihydrate in Resistance Research

  2026-08-17

  Build reproducible susceptibility, resistance-phenotyping, and metabolomics workflows around a broad-spectrum carbapenem antibiotic. Meropenem trihydrate helps connect routine bacterial assays with LC-MS/MS studies of carbapenemase-producing Enterobacterales and carefully controlled infection models.

• Moxifloxacin: A Mechanism-First Assay Guide

  2026-08-16

  Moxifloxacin is a fluoroquinolone antibiotic with applications extending from bacterial DNA topology assays to antibiotic toxicity research. This mechanism-first guide connects molecular target engagement with retinal-cell, metabolic, and in vivo readouts while defining practical interpretation limits.

554 records 7/37 page Previous Next First page 上5页 678910 下5页 Last page